Objective:

To explore the potential of home monitoring in managing retinal diseases, particularly age-related macular degeneration (AMD), and its significance in improving patient outcomes.

Approach:

Key Findings:

• Home monitoring can improve visual outcomes in AMD patients compared to standard monitoring, as evidenced by clinical studies.
• The SCANLY Home OCT device allows for quantitative monitoring of AMD-related changes, providing timely alerts for intervention.
• Outsourcing device management can enhance patient adherence to home monitoring programs, supported by real-world data.
• Home monitoring may reduce the frequency of in-office visits for AMD patients, potentially increasing clinic capacity.
• The potential for increased revenue through remote monitoring services exists, with specific billing codes facilitating this process.

Interpretation:

Home monitoring represents a promising advancement in the management of retinal diseases, potentially improving patient outcomes and clinic efficiency by allowing for timely interventions.

Limitations:

• Concerns about the burden on retina clinics in providing home monitoring services, including training and support.
• Uncertainty regarding the impact on practice revenue and patient visit patterns, as well as potential technological barriers for patients.

Conclusion:

Home monitoring has the potential to optimize patient care in retinal practices, improve compliance, and manage increasing patient volumes effectively, but addressing the limitations is crucial for successful implementation.

Sources:

• Notal Vision
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.